Compass Biotechnologies Stock Price Prediction
As of 28th of December 2025 the relative strength index (rsi) of Compass Biotechnologies' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Compass Biotechnologies' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Compass Biotechnologies, which may create opportunities for some arbitrage if properly timed.
For more detail on how to invest in Compass Stock please use our How to Invest in Compass Biotechnologies guide.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Compass Biotechnologies hype-based prediction, you can estimate the value of Compass Biotechnologies from the perspective of Compass Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Compass Biotechnologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Compass because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Compass Biotechnologies after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Compass Biotechnologies Basic Forecasting Models to cross-verify your projections. Compass Biotechnologies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Compass Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Compass Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Compass Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Compass Biotechnologies Hype Timeline
Compass Biotechnologies is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Compass is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Compass Biotechnologies is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.01. Compass Biotechnologies had not issued any dividends in recent years. The entity had 1:40 split on the 2nd of February 2009. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out Compass Biotechnologies Basic Forecasting Models to cross-verify your projections.Compass Biotechnologies Related Hype Analysis
Having access to credible news sources related to Compass Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Compass Biotechnologies' future price movements. Getting to know how Compass Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Compass Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BPTSY | Biophytis SA | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 112.54 | |
| BITRF | Biotron Limited | 0.00 | 0 per month | 0.00 | 0.15 | 0.00 | (18.75) | 1,057 | |
| RSPI | RespireRx Pharmaceuticals | 0.00 | 0 per month | 6.94 | 0.12 | 27.27 | (16.67) | 102.53 | |
| PFND | Pathfinder Cell Therapy | (0.13) | 19 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MCET | Multicell Techs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IPIX | Innovation Pharmaceuticals | 0.00 | 0 per month | 25.07 | 0.21 | 125.00 | (66.67) | 1,492 | |
| VIRX | Viracta Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TSOI | Therapeutic Solutions International | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 1,100 | |
| ERBB | American Green | 0.00 | 0 per month | 14.03 | 0.10 | 50.00 | (33.33) | 83.33 | |
| IDYLF | Imaging Dynamics | 0.00 | 3 per month | 0.00 | 0.12 | 0.00 | 0.00 | 152.69 |
Compass Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Compass price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Compass using various technical indicators. When you analyze Compass charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Compass Biotechnologies Predictive Indicators
The successful prediction of Compass Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Compass Biotechnologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Compass Biotechnologies based on analysis of Compass Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Compass Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Compass Biotechnologies's related companies. | 2010 | 2011 | 2024 | 2025 (projected) | Days Sales Outstanding | 46.7 | 10.39 | 11.95 | 11.35 | PTB Ratio | 52.89 | 4.84 | 5.57 | 5.29 |
Story Coverage note for Compass Biotechnologies
The number of cover stories for Compass Biotechnologies depends on current market conditions and Compass Biotechnologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Compass Biotechnologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Compass Biotechnologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Compass Stock analysis
When running Compass Biotechnologies' price analysis, check to measure Compass Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Biotechnologies is operating at the current time. Most of Compass Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Compass Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Biotechnologies' price. Additionally, you may evaluate how the addition of Compass Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |